JESSICA GAMBLE: Open Payments
NPI 1760667711 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 35 payments from 10 companies in 2025. Trend: 2023 $164 · 2024 $494 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $172 |
| Collegium Pharmaceutical, Inc. | 10 | $138 |
| ABBVIE INC. | 4 | $70 |
| BIOTRONIK NRO, Inc. | 2 | $54 |
| Forte Bio-Pharma LLC | 2 | $39 |
| SCILEX PHARMACEUTICALS INC. | 2 | $34 |
| Valinor Pharma, LLC | 2 | $32 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Boston Scientific Corporation | 1 | $16 |
| SPR Therapeutics, Inc | 1 | $14 |
Products named: RELISTOR, XTAMPZA, UBRELVY, Prospera, PROLATE, ZTLido, MOVANTIK, JOURNAVX.
Industry payments across TX — which companies pay providers there.
